Opdualag Den Europæiske Union - dansk - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Imjudo Den Europæiske Union - dansk - EMA (European Medicines Agency)

imjudo

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastiske midler - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Grazax 75.000 SQ.T Frysetørret sublingual tablet Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

grazax 75.000 sq.t frysetørret sublingual tablet

alk-abello a/s - engrottehale (græspollenallergen) - frysetørret sublingual tablet - 75.000 sq.t

Grazax 75.000 SQ.T frysetørret tablet Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

grazax 75.000 sq.t frysetørret tablet

abacus medicine a/s - eng-rottehale - frysetørret tablet - 75.000 sq.t

Grazax 75.000 SQ.T frysetørret tablet Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

grazax 75.000 sq.t frysetørret tablet

paranova danmark a/s - eng-rottehale - frysetørret tablet - 75.000 sq.t

Grazax 75.000 SQ.T Frysetørret sublingual tablet Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

grazax 75.000 sq.t frysetørret sublingual tablet

orifarm a/s - engrottehale (græspollenallergen) - frysetørret sublingual tablet - 75.000 sq.t

Hexavac Den Europæiske Union - dansk - EMA (European Medicines Agency)

hexavac

sanofi pasteur msd, snc - renset difteri toxoid, renset tetanus toxoid, renset kighoste toxoid, renset kighoste trådet hæmagglutinin, hepatitis b surface antigen, inaktiveret poliovirus type 1 (mahoney), inaktiveret poliovirus type 2 (mef 1), inaktiveret poliovirus type 3 (saukett), haemophilus influenzae type b polysakkarid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vacciner - denne kombinerede vaccine er indiceret til primære og booster vaccination af børn mod difteri, stivkrampe, kighoste, hepatitis b forårsaget af alle kendte subtyper af vira, polio og invasive infektioner forårsaget af haemophilus influenzae type b.

Nimenrix Den Europæiske Union - dansk - EMA (European Medicines Agency)

nimenrix

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningitis, meningokok - vacciner - nimenrix er indiceret til aktiv immunisering af personer fra 6 uger mod invasive meningokoksygdomme forårsaget af neisseria meningitidis gruppe a, c, w-135 og y.